Recombinant multi-species PBK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PBK protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. Evidence suggests that mitotic phosphorylation is required for its catalytic activity. The encoded protein may be involved in the activation of lymphoid cells and support testicular functions, with a suggested role in the process of spermatogenesis. Overexpression of this gene has been implicated in tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
The Alternative Names of target: 2810434B10Rik,CT84,Cancer/testis antigen 84 (CT84),D14Ertd732e,HEL164,Lymphokine-activated killer T-cell-originated protein kinase,MAPKK-like protein kinase,Nori-3,PBK,PDZ-binding kinase,Pbk,SPK,Spermatogenesis-related protein kinase (SPK),T-LAK cell-originated protein kinase,TOPK
Go
to PBK products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T98642-Ag-1/ GM-Tg-hg-T98642-Ag-2 | Human PBK protein | Human |
| GM-Tg-rg-T98642-Ag-1/ GM-Tg-rg-T98642-Ag-2 | Rat PBK protein | Rat |
| GM-Tg-mg-T98642-Ag-1/ GM-Tg-mg-T98642-Ag-2 | Mouse PBK protein | Mouse |
| GM-Tg-cynog-T98642-Ag-1/ GM-Tg-cynog-T98642-Ag-2 | Cynomolgus/Rhesus macaque PBK protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T98642-Ag-1/ GM-Tg-felg-T98642-Ag-2 | Feline PBK protein | Feline |
| GM-Tg-cang-T98642-Ag-1/ GM-Tg-cang-T98642-Ag-2 | Canine PBK protein | Canine |
| GM-Tg-bovg-T98642-Ag-1/ GM-Tg-bovg-T98642-Ag-2 | Bovine PBK protein | Bovine |
| GM-Tg-equg-T98642-Ag-1/ GM-Tg-equg-T98642-Ag-2 | Equine PBK protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T98642-Ag-1/ GM-Tg-hg-T98642-Ag-2;
GM-Tg-rg-T98642-Ag-1/ GM-Tg-rg-T98642-Ag-2;
GM-Tg-mg-T98642-Ag-1/ GM-Tg-mg-T98642-Ag-2; GM-Tg-cynog-T98642-Ag-1/ GM-Tg-cynog-T98642-Ag-2; GM-Tg-felg-T98642-Ag-1/ GM-Tg-felg-T98642-Ag-2; GM-Tg-cang-T98642-Ag-1/ GM-Tg-cang-T98642-Ag-2; GM-Tg-bovg-T98642-Ag-1/ GM-Tg-bovg-T98642-Ag-2; GM-Tg-equg-T98642-Ag-1/ GM-Tg-equg-T98642-Ag-2 |
| Products Name | PBK protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PBK |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PBK protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.